-65.7%
MRNA vs ALB
-48.5%
-17.2%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | ALB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -3.4% | +8.8% | +6.5% |
| 7D | -1.1% | -6.6% | +5.5% | +0.9% |
| 30D | +126.1% | -8.1% | +134.2% | +131.6% |
| 3M | +190.0% | -25.7% | +215.7% | +215.3% |
| 6M | +157.2% | -29.5% | +186.7% | +180.6% |
| YTD | +388.2% | -16.2% | +404.4% | +404.3% |
| 1Y | +467.0% | +59.2% | +407.8% | +377.7% |
| 3Y | +36.1% | -33.7% | +69.8% | +37.7% |
| All | -65.7% | -48.5% | -17.2% | -69.5% |
Cumulative growth
Daily Returns
Daily percentage return beside ALB.
Daily Out/Under-Performance
Portfolio return minus ALB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded ALB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling